Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
Small win for improved access to naloxone
Monday 1 August 2022, 04:30 AM

Drug Foundation policy director Kali Mercier wishes the MCC had made naloxone a generalsale medicine [Image – Hagen Hopkins Photography]
The NZ Drug Foundation is pleased the Medicines Classification Committee has removed some of the red tape blocking access to the lifesaving, overdosereversal medication naloxone, although it wishes the committee’s recommendations had gone further.
We had hoped the MCC would have gone further and made all types of naloxone available over the counter
At its meeting on 26 April, which has its
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.